HISTORICAL FACTS: Vtv - The Untold Story

Actively Managed ETFs Are Giving In to the Price War—To the Benefit of Investors

Low-fee active ETFs DFLV, DFAC, and USMC now rival passive funds on cost, but comparisons with Vanguard alternatives show mixed performance and liquidity trade-offs for investors.

MarketBeat · Oct 26

Tech Wreck or Valuation Reset? Rotating to Value in 2026

Rotating toward established value sectors provides a strategic opportunity to capture consistent dividends and capitalize on steady corporate performance.

MarketBeat · Jan 13

Flash flood sweeps away hamlet as Vietnam storm toll rises to 141 dead

A flash flood swept away a hamlet in northern Vietnam, killing 16 people and leaving dozens missing as deaths from a typhoon and its aftermath climbed to 141

The Independent UK · Sep 11, 2024

‘Tavriya TV will promote happiness and love’: Russia opens station in occupied Kherson

As Moscow gears up to annex Kherson in a ‘referendum’, Tavriya shows Russia as liberator, saving citizens from Ukrainian Nazis

The Guardian - UK · Aug 27, 2022

5 Best Value ETFs to Buy as Interest Rates Rise

Inflationary pressure, worsening supply chain disruptions, and the prospect of aggressive interest rate hikes later this year have been contributing to a turbulent stock market. Because these factors are unlikely to change anytime soon, we believe investors seeking long-term gain should consider investing in quality value ETFs Vanguard Value (VTV),…

StockNews.com · Apr 26, 2022

5 Top ETFs to Buy for April

After stabilizing for a brief period, the major market indexes have tumbled again lately on concerns over further sanctions on Russia in response to its invasion of Ukraine and more extensive interest rate hikes by the Fed to tame inflation. Amid the market uncertainty, ETF investing is an effective way…

StockNews.com · Apr 7, 2022

The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga · Mar 4, 2022